AvenCell

Series-B+
avencell.com Biotech & Healthcare Cambridge, United States Founded 2021 51-100
Total Funding $112M
Latest Round $112M Series-B+
Last Announced Oct 22, 2024
Investors 8 Backers
Decision Makers 6 Verified

About AvenCell

Based on our deep science and focused on patients in need.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cambridge, United States
Year Founded 2021
Team Size 51-100
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website avencell.com
Domain Registered Date Jul 27, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $112,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    Website domain registered

    avencell.com

  3. Milestone

    Company founded

    Cambridge, United States

Investors & Backers

8
AMED
Blackstone Life Sciences
Eight Roads Ventures Japan
F-Prime Capital
Ligand Pharmaceuticals
Novo Holdings
NYBC Ventures
Piper Heartland Healthcare Capital

Funding History

1 Round
Series-B+ · Oct 22, 2024

Founders & Leadership

4

Andrew D. Schiermeier

Founder

Work email & phone locked Unlock →

Gerhard Ehninger

Chief Medical Officer

Work email & phone locked Unlock →

James Feliciano

Fractional General Manager

Work email & phone locked Unlock →

Markus Orchowski

Vice President Operations

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts